Australia's CSL said on Wednesday it has got a contract from the U.S. Department of Health and Human Services (HHS) worth ...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...

(Reuters) -Australia's CSL said on Wednesday it has got a contract from the U.S. Department of Health and Human Services (HHS ...

CSL Ltd. (CMXHF.PK) and Arcturus Therapeutics Holdings Inc. (ARCT), Monday announced that self-amplifying or sa-mRNA COVID-19 vaccine ...

Australia's CSL said on Wednesday it has got a contract from the U.S. Department of Health and Human Services (HHS) worth ...

Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and self-amplifying messenger RNA (sa-mRNA) pioneer Arcturus ...

Vaccine maker CSL Seqirus has lined up yet another contract with the U.S. | With a $121.4 million award from the U.S.

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

CSL's revenue has fluctuated over the last three years, with a decline in 2023 due to market instability. Read why I rate CSL ...

Earnings season has unveiled promising opportunities in health stocks, with Telix and CSL standing out as key gems.

It will also pull in a nice amount of revenue for CSL. The company will receive US$121.4 million from the multi-year award.

CSL Seqirus has secured a fresh $121.4 million contract with the US Biomedical Advanced Research and Development Authority to ...